No evidence of substantia nigra telomere shortening in Parkinson's disease

Neurobiology of Aging

Volumn 32, Issue 11, 2011, Pages 2107.e3-2107.e5

  Hudson, Gavin ^a   Faini, David ^a   Stutt, Andrea ^b   Eccles, Martin ^c   Robinson, Louise ^c   Burn, David J ^b   Chinnery, Patrick F ^a,b  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Parkinson's disease; Smoking; Telomere

Indexed keywords

MITOCHONDRIAL DNA; REACTIVE OXYGEN METABOLITE;

ARTICLE; BLOOD ANALYSIS; BRAIN REGION; CONTROLLED STUDY; CORRELATIONAL STUDY; DISEASE ASSOCIATION; GENETIC VARIABILITY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; PARKINSON DISEASE; PATHOGENESIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; SMOKING; SUBSTANTIA NIGRA; TELOMERE; TELOMERE LENGTH;

EID: 80052611951     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2011.05.022     Document Type: Article

References (10)

1. De Palma G., Dick F.D., Calzetti S., Scott N.W., Prescott G.J., Osborne A., Haites N., Mozzoni P., Negrotti A., Scaglioni A., Mutti A. A case-control study of Parkinson's disease and tobacco use: gene-tobacco interactions. Mov. Disord 2010, 25:912-919. Geoparkinson Study Group.
2. Guan J.Z., Maeda T., Sugano M., Oyama J., Higuchi Y., Suzuki T., Makino N. A percentage analysis of the telomere length in Parkinson's disease patients. Journals Gerontology 2008, 63:467-473.
3. Honig L.S., Schupf N., Lee J.H., Tang M.X., Mayeux R. Shorter telomeres are associated with mortality in those with APOE epsilon4 and dementia. Ann. Neurol 2006, 60:181-187.
4. Martin-Ruiz C., Dickinson H.O., Keys B., Rowan E., Kenny R.A., Von Zglinicki T. Telomere length predicts poststroke mortality, dementia, and cognitive decline. Ann. Neurol 2006, 60:174-180.
5. Mirabello L., Huang W.Y., Wong J.Y., Chatterjee N., Reding D., Crawford E.D., De Vivo I., Hayes R.B., Savage S.A. The association between leukocyte telomere length and cigarette smoking, dietary and physical variables, and risk of prostate cancer. Aging Cell 2009, 8:405-413.
6. Moreno-Loshuertos R., Acín-Pérez R., Fernández-Silva P., Movilla N., Pérez-Martos A., Rodriguez de Cordoba S., Gallardo M.E., Enríquez J.A. Differences in reactive oxygen species production explain the phenotypes associated with common mouse mitochondrial DNA variants. Nat. Genet 2006, 38:1261-1268.
7. Prowse K.R., Greider C.W. Developmental and tissue-specific regulation of mouse telomerase and telomere length. Proc. Natl. Acad. Sci. U. S. A. 1995, 92:4818-4822.
8. Thomas P., O'Callaghan N.J., Fenech M. Telomere length in white blood cells, buccal cells and brain tissue and its variation with ageing and Alzheimer's disease. Mech. Ageing Dev 2008, 129:183-190.
9. Wang H., Chen H., Gao X., McGrath M., Deer D., De Vivo I., Schwarzschild M.A., Ascherio A. Telomere length and risk of Parkinson's disease. Mov. Disord 2008, 23:302-305.
10. Wang J.C., Warner J.K., Erdmann N., Lansdorp P.M., Harrington L., Dick J.E. Dissociation of telomerase activity and telomere length maintenance in primitive human hematopoietic cells. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:14398-14403.